<DOC>
	<DOCNO>NCT02606201</DOCNO>
	<brief_summary>Stress urinary incontinence relate intrinsic sphincter deficiency ( ISD ) severe form incontinence may major impact quality life . The main treatment surgical consist implantation medical device artificial urinary sphincter , adjustable continence therapy , compressive sling , injection bulking agent . The investigator develop new therapeutic strategy ISD consist implant myofibers attach satellite cell ( main source muscle progenitor cell ) vicinity striate urethral sphincter . The principle method relies vivo activation satellite cell lead formation regenerate myofibers ( myotubes ) generate distinct tonic muscular activity . The proof concept investigate Phase I clinical trial : Investigator find periurethral implantation myofiber strip around urethra generate electromyographic activity improve urethral closure pressure woman severe urinary incontinence associate ISD . In previous study , technique myofiber implantation invasive , require surgical approach dissection urethra place myofiber . For clinical trial IPSMA , investigator seek optimize myofiber transplantation process use method injection myofibers core obtain hydro-dissection . The injection technique perform percutaneously fluoroscopic endoscopic control require surgical approach urethra . This clinical trial prospective , open-label , non-randomized , uncontrolled , single-center first stage multicenter second stage , 13 month patient aim assess efficacy safety IPSMA treatment urinary incontinence woman ISD .</brief_summary>
	<brief_title>Peri-sphincter Injection Autologous Myofibres Treat Urinary Incontinence Sphincter Deficiency</brief_title>
	<detailed_description>The investigator choose assessment method 2 stage accord Simon plane . A total 38 patient need . Assuming ratio 10 % lose patient primary endpoint evaluable , 4 additional patient include total 42 patient include . This trial single-center first stage multicenter second stage . 11 patient include first stage 31 patient second stage .</detailed_description>
	<mesh_term>Urinary Incontinence</mesh_term>
	<mesh_term>Enuresis</mesh_term>
	<criteria>Female . Age &gt; = 18 year . Patients stress urinary incontinence ISD least 6 month Failure Pelvic ﬂoor muscle training ( least 20 session ) . Fixed urethra : negative Ulmsten test / Qtip test &lt; 30 ° 24h Pad test &gt; 50 g Urodynamic criterion : LPP ( leak point pressure ) &lt; 100 cm H20 MUCP &lt; 50 cm H2O Collection inform write consent Not affiliate social security scheme Trouble hemostasis know Untreated urinary tract infection Muscle disease genetically determine acquire Patients urinary incontinence vesicaurethral hypermobility Incomplete bladder emptying : post void residual &gt; 20 % volume void urination &gt; 150cc maximum urinary flow rate &lt; 12 ml / sec overactive bladder Bladder capacity ( B3 ) &lt; 200 cc Urethral stricture Anticoagulant therapy replace low molecular weight heparin Pregnant intend become pregnant study period breastfeed informed patient consultation .</criteria>
	<gender>Female</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>October 2015</verification_date>
	<keyword>stress urinary incontinence</keyword>
	<keyword>intrinsic sphincter deficiency</keyword>
	<keyword>myofiber</keyword>
	<keyword>autologous</keyword>
	<keyword>skeletal muscle precursor cell</keyword>
	<keyword>autologous serum</keyword>
</DOC>